ASSET | DATE | % RETURN |
---|---|---|
Agape ATP Corporation Common Stock (ATPC) | 10/10/2019 - 11/21/2019 | 550% |
Castellum (CTM) | 10/10/2019 - 11/21/2019 | 380% |
N2OFF (NITO) | 10/10/2019 - 11/21/2019 | 231.11% |
Relmada Therapeutics (RLMD) | 10/10/2019 - 11/21/2019 | 171.46% |
FuelCell Energy (FCEL) | 10/10/2019 - 11/21/2019 | 148.39% |
Fulcrum Therapeutics (FULC) | 10/10/2019 - 11/21/2019 | 141.41% |
Nocera (NCRA) | 10/10/2019 - 11/21/2019 | 137.5% |
Kazia Therapeutics Ltd ADR (KZIA) | 10/10/2019 - 11/21/2019 | 126.3% |
Xunlei Ltd Adr (XNET) | 10/10/2019 - 11/21/2019 | 122.77% |
Datasea (DTSS) | 10/10/2019 - 11/21/2019 | 119.25% |
Mersana Therapeutics (MRSN) | 10/10/2019 - 11/21/2019 | 113.91% |
Oncolytics Biotech (ONCY) | 10/10/2019 - 11/21/2019 | 111.54% |
Senmiao Technology (AIHS) | 10/10/2019 - 11/21/2019 | 110.29% |
Nutex Health (NUTX) | 10/10/2019 - 11/21/2019 | 104% |
Bloom Energy (BE) | 10/10/2019 - 11/21/2019 | 100% |
Progyny (PGNY) | 10/10/2019 - 11/21/2019 | 100% |
Arvinas (ARVN) | 10/10/2019 - 11/21/2019 | 96.66% |
InMode (INMD) | 10/10/2019 - 11/21/2019 | 96.13% |
Axsome Therapeutics (AXSM) | 10/10/2019 - 11/21/2019 | 92.99% |
Comscore (SCOR) | 10/10/2019 - 11/21/2019 | 90.28% |
Aquestive Therapeutics (AQST) | 10/10/2019 - 11/21/2019 | 90.18% |
Adverum Biotechnologies (ADVM) | 10/10/2019 - 11/21/2019 | 89.34% |
Aspira Womens Health (AWH) | 10/10/2019 - 11/21/2019 | 87.82% |
Kodiak Sciences (KOD) | 10/10/2019 - 11/21/2019 | 86.52% |
BridgeBio Pharma (BBIO) | 10/10/2019 - 11/21/2019 | 84.08% |